Table 3 Prevalence of class 1 integrons among blaVIM-positive isolates
No. screened | No. (%) with blaVIM | No. (%) with blaVIM + class 1 integron | ||
|---|---|---|---|---|
Positive | Negative | Positive | Negative | |
CRPA (25) | 25 (100) | 0 (0) | 16 (64) | 9 (36) |
CRAB (21) | 21 (100) | 0 (0) | 13 (62) | 8 (38) |